RESUMO
The widespread use of antibiotics has increased their presence in wastewater, largely due to inadequate removal by conventional treatment methods. This highlights a critical need for effective degradation strategies to mitigate environmental and public health risks. This study reports the photocatalytic degradation of amoxicillin (AMX) using calcium zinc hydroxide dihydrate [CaZn2(OH)6·2H2O] (CZ) and zinc oxide (ZnO) nanoparticles (NPs) synthesized by different routes. X-ray diffraction results confirmed the formation of CZ NPs with an 81-95% crystalline phase, while ZnO NPs present a single crystalline phase. The photolysis of AMX under UV-A light (365 nm) was strongly pH-dependent, with degradation rates of 34.7, 5.7, and 4.2% observed at pH 3, 5, and 13, respectively. Maximum adsorption occurred at pH 3, with ZnO achieving 63-83.2% AMX removal and 23.5-47.1% in the case of CZ. The highest overall AMX removal was observed at pH 3, where adsorption dominated the photocatalytic process for both CZ and ZnO. At pH 5 and 13, degradation was primarily driven by photocatalysis in CZ materials, particularly CZ-HT and CZ-SG, while adsorption remained predominant in ZnO. Proton nuclear magnetic resonance analysis indicates benzene ring cleavage in AMX photodegraded by CZ materials. Furthermore, the residues of photodegraded AMX by CZ materials lost antimicrobial activity against Gram-positive and Gram-negative bacteria. Additionally, the reuse of NPs over four cycles maintained consistent degradation performance, highlighting their potential for repeated applications. The comparative analysis of CZ and ZnO NPs superior photocatalytic efficiency of CZ in degrading AMX. This efficiency, along with its potential for repeated use, establish CZ as a promising material for environmental applications aimed at reducing antibiotic contamination and the associated risks of resistance development.
Assuntos
Amoxicilina , Antibacterianos , Fotólise , Poluentes Químicos da Água , Óxido de Zinco , Amoxicilina/química , Óxido de Zinco/química , Catálise , Poluentes Químicos da Água/química , Antibacterianos/química , Nanopartículas/química , Águas Residuárias/química , Adsorção , Raios UltravioletaRESUMO
Due to its widespread use and incomplete breakdown in the human body, amoxicillin has been detected in receiving water bodies. This raises significant concerns, like the promotion of antibiotic resistance, toxicity towards aquatic life, disruption of the natural balance of microbial communities within these water bodies, and the struggle of effectively removal by the traditional wastewater treatment plants. Consequently, exploring new processes to complement the existing methods is crucial. Adsorption, a promising highly efficient, selective, and versatile technique, can effectively remove contaminants, making it useful in various industries such as water treatment, pharmaceuticals, and environmental remediation. Several adsorbents are documented in the literature for drug adsorption; however, their fabrication often involves more complex steps and substances compared to chitosan and alginate, which are natural polymers that are biocompatible, non-toxic, and biodegradable. Their tunable properties and ease of modification enhance their efficacy in environmental remediation. Therefore, the novelty of this article is to understand the interaction of amoxicillin with chitosan and alginate adsorbents easily synthetized using the dripping technique. This approach allows us to explore basic principles that can be applied to more complex systems in future studies. The optimal pH for both beads was found to be 4, with adsorption capacities of 74.2 ± 0.3 mg g-1 for alginate and 80.4 ± 0.2 mg g-1 for chitosan, using 1 g of adsorbent. Kinetics studies indicated that external diffusion governs adsorption for alginate, while internal diffusion governs adsorption for chitosan. This approach underscores the potential of chitosan and alginate beads as effective adsorbents for mitigating antibiotic contamination in water systems, offering a sustainable complement to traditional treatment methods.
Assuntos
Alginatos , Amoxicilina , Quitosana , Poluentes Químicos da Água , Quitosana/química , Amoxicilina/química , Alginatos/química , Adsorção , Biopolímeros/química , Poluentes Químicos da Água/química , Purificação da Água/métodosRESUMO
Candida albicans invasive candidiasis is considered a global health problem. In such cases, biofilm formation on implanted devices represents a therapeutic challenge and the presence of metabolically inactive persistent cells (PCs) in these communities increases their tolerance to fungicidal drugs. This study investigated the influence of amoxicillin, AMX; cefepime, CEF; gentamicin, GEN; amikacin, AMK; vancomycin, VAN; and ciprofloxacin, CIP; on the production of PCs in biofilms of C. albicans bloodstream isolates. 48 h-mature biofilms (n = 6) grown in RPMI-1640 supplemented with antibiotics were treated with 100 µg ml-1 amphotericin B and then evaluated for PCs. Biofilms grown in the presence of antibiotics produced more PCs, up to 10×, when exposed to AMX and CIP; 5 × to CEF; and 6 × to GEN and VAN. The results indicate that antibiotics can modulate PC production in C. albicans biofilms. This scenario may have clinical repercussions in immunocompromised patients under broad-spectrum antibiotic therapy.
Biofilms are microbial communities tolerant to antifungals. Our research showed that antibiotics stimulate the formation of persistent cells within Candida albicans biofilms. These are dormant, metabolically silent cells that resist to therapy and can be related to metastatic and recalcitrant infections.
Assuntos
Antibacterianos , Biofilmes , Candida albicans , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Candida albicans/efeitos dos fármacos , Candida albicans/fisiologia , Antibacterianos/farmacologia , Humanos , Antifúngicos/farmacologia , Testes de Sensibilidade Microbiana , Ciprofloxacina/farmacologia , Gentamicinas/farmacologia , Amoxicilina/farmacologia , Vancomicina/farmacologia , Amicacina/farmacologia , Cefepima/farmacologia , Anfotericina B/farmacologia , Cefalosporinas/farmacologia , Candidíase/microbiologia , Candidíase/tratamento farmacológicoRESUMO
INTRODUCTION: Gastric cancer (GC) is one of the most lethal malignancies worldwide. Helicobacter pylori is the primary cause of GC; therefore, its eradication reduces the risk of developing this neoplasia. There is extensive evidence regarding quadruple therapy with relevance to the European population. However, in Latin America, data are scarce. Furthermore, there is limited information about the eradication rates achieved by antibiotic schemes in European and Latin American populations. OBJECTIVE: To compare the effectiveness of standard triple therapy (STT), quadruple concomitant therapy (QCT), and bismuth quadruple therapy (QBT) in six centers in Europe and Latin America. METHODS: A retrospective study was carried out based on the LEGACy registry from 2017 to 2022. Data from adult patients recruited in Portugal, Spain, Chile, Mexico, and Paraguay with confirmed H. pylori infection who received eradication therapy and confirmatory tests at least 1 month apart were included. Treatment success by each scheme was compared using a mixed multilevel Poisson regression, adjusting for patient sex and age, together with country-specific variables, including prevalence of H. pylori antibiotic resistance (clarithromycin, metronidazole, and amoxicillin), and CYP2C19 polymorphisms. RESULTS: 772 patients were incorporated (64.64% females; mean age of 52.93 years). The total H. pylori eradication rates were 75.20% (255/339) with STT, 88.70% (159/178) with QCT, and 91.30% (191/209) with QBT. Both quadruple therapies (QCT-QBT) showed significantly higher eradication rates compared with STT, with an adjusted incidence risk ratio (IRR) of 1.25 (p: <0.05); and 1.24 (p: <0.05), respectively. The antibiotic-resistance prevalence by country, but not the prevalence of CYP2C19 polymorphism, showed a statistically significant impact on eradication success. CONCLUSIONS: Both QCT and QBT are superior to STT for H. pylori eradication when adjusted for country-specific antibiotic resistance and CYP2C19 polymorphism in a sample of individuals residing in five countries within two continents.
Assuntos
Antibacterianos , Quimioterapia Combinada , Infecções por Helicobacter , Helicobacter pylori , Inibidores da Bomba de Prótons , Humanos , Infecções por Helicobacter/tratamento farmacológico , Masculino , Feminino , Helicobacter pylori/efeitos dos fármacos , Pessoa de Meia-Idade , Antibacterianos/uso terapêutico , América Latina/epidemiologia , Estudos Retrospectivos , Europa (Continente)/epidemiologia , Inibidores da Bomba de Prótons/uso terapêutico , Inibidores da Bomba de Prótons/administração & dosagem , Adulto , Resultado do Tratamento , Metronidazol/uso terapêutico , Idoso , Amoxicilina/uso terapêutico , Amoxicilina/administração & dosagem , Citocromo P-450 CYP2C19/genética , Farmacorresistência Bacteriana , Bismuto/uso terapêutico , Bismuto/administração & dosagem , Neoplasias Gástricas/microbiologia , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/epidemiologia , Claritromicina/uso terapêuticoRESUMO
Although Streptococcus pyogenes and Candida albicans may colonize tonsillar tissues, the interaction between them in mixed biofilms has been poorly explored. This study established an interkingdom biofilm model of S. pyogenes and C. albicans and verified the dose-response validation of antimicrobials. Biofilms were formed on microplates, in the presence or absence of a conditioning layer of human saliva, using Brain Heart Infusion (BHI) broth or artificial saliva (AS) as a culture medium, and with variations in the microorganism inoculation sequence. Biofilms grown in AS showed higher mass than those grown in BHI broth, and an opposite trend was observed for metabolism. The number of S. pyogenes colonies was lower in AS. Amoxicillin and nystatin showed dose-dependent effects. The inoculation of the two species at the same time, without prior exposure to saliva, and using BHI broth would be the model of choice for future studies assessing the effects of antimicrobials on dual S. pyogenes/C. albicans biofilms.
Assuntos
Biofilmes , Candida albicans , Streptococcus pyogenes , Candida albicans/efeitos dos fármacos , Candida albicans/fisiologia , Biofilmes/efeitos dos fármacos , Streptococcus pyogenes/efeitos dos fármacos , Streptococcus pyogenes/fisiologia , Humanos , Relação Dose-Resposta a Droga , Saliva/microbiologia , Testes de Sensibilidade Microbiana , Meios de Cultura/química , Amoxicilina/farmacologia , Nistatina/farmacologia , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologiaRESUMO
The aim of the present study was first to isolate Helicobacter pylori from gastric biopsy specimens and to test their antibiotic susceptibility. Second, it was to evaluate the efficacy of the standard triple therapy from patients of the west central region of Colombia. H. pylori positive patients received standard triple therapy with proton pump inhibitor (PPI) (40 mg b.i.d.), clarithromycin (500 mg b.i.d.), and amoxicillin (1 g b.i.d.) for 14 days. Thereafter, antibiotic susceptibility of the isolates was assessed by E-Test. From 94 patients enrolled, 67 were positive for H. pylori by histology or culture. Overall resistance to metronidazole, levofloxacin, rifampicin, clarithromycin, and amoxicillin was 81%, 26.2%, 23.9%, 19%, and 9.5%, respectively. No resistance was found for tetracycline. A total of 54 patients received standard triple therapy, 48 attended follow-ups testing, and of them, 30 had resistance test reports. Overall eradication rate was 81.2%. Second-line treatment was given to eight patients, four of whom were followed up with a 13C urea breath test (UBT) and remained positive for H. pylori. Eradication was significantly higher in patients with clarithromycin susceptible than in resistant strains (95.6% vs 42.8% P = 0.001). The updated percentages of resistance to clarithromycin in this geographical area had increased, so this value must be considered when choosing the treatment regimen.IMPORTANCEAntibiotic resistance in Helicobacter pylori has increased worldwide, as has resistance to multiple antimicrobials (MDRs), which seriously hampers the successful eradication of the infection. The ideal success rate in eradicating H. pylori infection (≥90%) was not achieved in this study (81.2%). This is the first time that MDR is reported (14.3%) in the region; the resistance to clarithromycin increased over time (3.8%-19%), and levofloxacin (26.2%) and rifampicin (23%) resistant isolates were detected for the first time. With these results, strain susceptibility testing is increasingly important, and the selection of treatment regimen should be based on local antibiotic resistance patterns.
Assuntos
Amoxicilina , Antibacterianos , Claritromicina , Quimioterapia Combinada , Infecções por Helicobacter , Helicobacter pylori , Testes de Sensibilidade Microbiana , Humanos , Helicobacter pylori/efeitos dos fármacos , Helicobacter pylori/isolamento & purificação , Helicobacter pylori/genética , Colômbia , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/microbiologia , Masculino , Feminino , Pessoa de Meia-Idade , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Adulto , Claritromicina/farmacologia , Claritromicina/uso terapêutico , Amoxicilina/uso terapêutico , Amoxicilina/farmacologia , Idoso , Inibidores da Bomba de Prótons/uso terapêutico , Farmacorresistência Bacteriana , Adulto Jovem , Metronidazol/uso terapêutico , Metronidazol/farmacologia , Levofloxacino/farmacologia , Levofloxacino/uso terapêutico , Resultado do TratamentoRESUMO
Periodontal mechanical debridement is the most common therapy for the treatment of periodontitis. However, depending on the severity of the disease, mechanical debridement has been recommended in combination with systemic antibiotics. In this study, we performed an overview of systematic reviews using the Friendly Summaries of Body of Evidence using Epistemonikos (FRISBEE) methodology on the effectiveness and safety of mechanical debridement combined with amoxicillin and metronidazole compared to mechanical debridement alone for the treatment of chronic periodontitis. We conducted a systematic search of the Epistemonikos database, extracted data from 10 systematic reviews and re-analyzed data from 23 primary studies to generate a summary of findings (SoF) table. We used RevMan 5.3 and GRADEpro for data analysis and data presentation. The following outcomes were analyzed: probing depth (mean difference (MD): 0.07 mm); clinical attachment level (MD: 0.04 mm); bleeding on probing (MD: 5.06%); and suppuration (MD: 0.31%). There was no evidence of a clinically relevant benefit of periodontal mechanical debridement therapy combined with amoxicillin and metronidazole compared to periodontal mechanical debridement therapy alone for the treatment of chronic periodontitis in the studied periodontal outcomes.
Assuntos
Amoxicilina , Antibacterianos , Periodontite Crônica , Metronidazol , Desbridamento Periodontal , Humanos , Amoxicilina/uso terapêutico , Amoxicilina/administração & dosagem , Antibacterianos/uso terapêutico , Periodontite Crônica/terapia , Periodontite Crônica/tratamento farmacológico , Terapia Combinada , Metronidazol/uso terapêutico , Metronidazol/administração & dosagem , Desbridamento Periodontal/métodosRESUMO
BACKGROUND: Treatment of Helicobacter pylori gastric infection is complex and associated with increased rates of therapeutic failure. This research aimed to characterize the H. pylori infection status, strain resistance to antimicrobial agents, and the predominant lesion pattern in the gastroduodenal mucosa of patients with clinical suspicion of refractoriness to first- and second-line treatment who were diagnosed and treated in a health center in Guayaquil, Ecuador. METHODS: A total of 374 patients with upper gastrointestinal symptoms and H. pylori infection were preselected and prescribed one of three triple therapy regimens for primary infection, as judged by the treating physician. Subsequently, 121 patients who returned to the follow-up visit with persistent symptoms after treatment were studied. RESULTS: All patients had H. pylori infection. Histopathological examination diagnosed chronic active gastritis in 91.7% of cases; premalignant lesions were observed in 15.8%. The three triple therapy schemes applied showed suboptimal efficacy (between 47.6% and 77.2%), with the best performance corresponding to the scheme consisting of a proton pump inhibitor + amoxicillin + levofloxacin. Bacterial strains showed very high phenotypic resistance to all five antimicrobials tested: clarithromycin, 82.9%; metronidazole, 69.7%; amoxicillin and levofloxacin, almost 50%; tetracycline, 38.2%. Concurrent resistance to clarithromycin-amoxicillin was 43.4%, to tetracycline-metronidazole 30.3%, to amoxicillin-levofloxacin 27.6%, and to clarithromycin-metronidazole 59.2%. CONCLUSIONS: In vitro testing revealed resistance to all five antibiotics, indicating that H. pylori exhibited resistance phenotypes to these antibiotics. Consequently, the effectiveness of triple treatments may be compromised, and further studies are needed to assess refractoriness in quadruple and concomitant therapies.
Assuntos
Anti-Infecciosos , Infecções por Helicobacter , Helicobacter pylori , Humanos , Claritromicina/farmacologia , Claritromicina/uso terapêutico , Metronidazol/farmacologia , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/microbiologia , Levofloxacino/farmacologia , Equador , Antibacterianos/farmacologia , Amoxicilina/farmacologia , Tetraciclina/uso terapêutico , Tetraciclina/farmacologia , Quimioterapia CombinadaRESUMO
Feed and water components may interact with drugs and affect their dissolution and bioavailability. The impact of the vehicle of administration (feed and water) and the prandial condition of weaner piglets on amoxicillin´s oral bioavailability was evaluated. First, amoxicillin's in vitro dissolution and stability in purified, soft, and hard water, as well as release kinetics from feed in simulated gastric and intestinal media were assessed. Then, pharmacokinetic parameters and bioavailability were determined in fasted and fed pigs using soft water, hard water, or feed as vehicles of administration following a balanced incomplete block design. Amoxicillin showed similar dissolution profiles in soft and hard water, distinct from the dissolution profile obtained with purified water. Complete dissolution was only achieved in purified water, and merely reached 50% in soft or hard water. Once dissolved, antibiotic concentrations decreased by around 20% after 24 h in all solutions. Korsmeyer-Peppas model best described amoxicillin release from feed in simulated gastric and intestinal media. Feed considerably reduced antibiotic dissolution in both simulated media. In vivo, amoxicillin exhibited significantly higher bioavailability when delivered via water to fasted than to fed animals, while in-feed administration yielded the lowest values. All treatments showed a similar rate of drug absorption. In conclusion, we demonstrated that water and feed components, as well as feed present in gastrointestinal tract of piglets decrease amoxicillin´s oral bioavailability. Therefore, the use of oral amoxicillin as a broad-spectrum antibiotic to treat systemic infections in pigs should be thoroughly revised.
Assuntos
Amoxicilina , Ração Animal , Antibacterianos , Disponibilidade Biológica , Animais , Amoxicilina/farmacocinética , Amoxicilina/administração & dosagem , Amoxicilina/sangue , Ração Animal/análise , Antibacterianos/farmacocinética , Antibacterianos/administração & dosagem , Antibacterianos/sangue , Administração Oral , Suínos , Água/química , Masculino , FemininoRESUMO
The aim of this study was to investigate the influence of systemic antibiotic therapy on the development and progression of induced apical periodontitis (AP) in Wistar rats. Fifty-six rats were submitted to pulp exposure of the lower left first molar for the induction of AP. On the same day, intraperitoneal antibiotic therapy was administered once a day, for 15 days, until euthanasia. The groups were formed according to the different treatments (n = 8): C-control; GEN-treated with gentamicin (10 mg/Kg); AC-treated with amoxicillin (100 mg/Kg); MZ-treated with metronidazole (40 mg/Kg); AMP-treated with ampicillin (100 mg/Kg); AMC group-treated with amoxicillin + clavulanic acid (100 mg/kg); CLI-treated with clindamycin (60 mg/kg). After euthanasia, the jaws were collected and processed for (1) histological and histometric analysis using hematoxylin and eosin staining, (2) analysis of collagen fibers using Picrosirius Red staining and (3) bacteriological analysis using Brown-Brenn staining. The data were analyzed statistically (p < 0.05). AP induction was confirmed in all groups. The AMC group had the lower intensity of inflammatory infiltrate (p = 0.028) and less periapical bone resorption compared to control (p = 0.006). Regarding collagen maturation, PSR staining revealed a predominance of mature collagen fibers in all groups. The AC and AMC groups had the lower amount of mature fibers and the highest amount of immature fibers, compared to all other groups (p < 0.001). All groups showed bacterial contamination; however, the AC and AMC groups showed a lower extent of bacterial contamination compared to the control (p < 0.001). It can be concluded that systemic antibiotic therapy influences the development and progression of induced AP.
Assuntos
Antibacterianos , Modelos Animais de Doenças , Progressão da Doença , Periodontite Periapical , Ratos Wistar , Animais , Periodontite Periapical/microbiologia , Periodontite Periapical/tratamento farmacológico , Ratos , Antibacterianos/farmacologia , Masculino , Ampicilina/farmacologia , Metronidazol/farmacologia , Amoxicilina/farmacologia , Gentamicinas , Clindamicina/uso terapêutico , Dente MolarRESUMO
INTRODUCTION: In Chile, more than 70% of adults are infected by Helicobacter pylori. Clarithromycin should not be used in any regimen if there is >15% resistance to this antibiotic, being greater than 26% in our population. In this scenario, the effectiveness of triple therapy (proton pump inhibitor [PPI], clarithromycin, amoxicillin) was only 63.8%. AIM: To evaluate the eradication rate and safety of dual therapy (esomeprazole and amoxicillin) in high doses, through a prospective, observational, and descriptive study. METHODS: Patients with a positive urease test obtained in an upper digestive endoscopy were included. Any other previous H. pylori eradication regimen were excluded. All patients were treated with esomeprazole 40 mg three times a day and amoxicillin 750 mg four times a day for 14 days. The eradication rate of the dual therapy was evaluated with the H. pylori stool antigen test (the Pylori-Strip® test used) 6 weeks after completing the eradication treatment and with at least 14 days without PPI, being a negative result, confirmation of the effectiveness of this regimen. RESULTS: Of 122 patients, 106 had a negative H. pylori antigen in stool; The intention-to-treat and per protocol analysis, the eradication rates were 91.8% [95% CI: 87%-97%] and 94% [95% CI: 90%-98%], respectively. Four patients discontinued treatment due to adverse effects. Smoking and adherence to treatment were associated with eradication rate. CONCLUSIONS: In this cohort of patients with H. pylori infection, high-dose dual therapy has a high eradication rate and good adherence, raising the possibility that it could be used as first-line therapy in our country. Studies with a larger number of patients should confirm these results.
Assuntos
Infecções por Helicobacter , Helicobacter pylori , Adulto , Humanos , Amoxicilina , Antibacterianos , Chile , Claritromicina/uso terapêutico , Quimioterapia Combinada/efeitos adversos , Esomeprazol/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Hospitais , Estudos Prospectivos , Inibidores da Bomba de Prótons , Resultado do TratamentoRESUMO
Control measures are being introduced globally to reduce the prevalence of antibiotic resistance (ABR) in bacteria on farms. However, little is known about the current prevalence and molecular ecology of ABR in bacterial species with the potential to be key opportunistic human pathogens, such as Escherichia coli, on South American farms. Working with 30 dairy cattle farms and 40 pig farms across two provinces in central-eastern Argentina, we report a comprehensive genomic analysis of third-generation cephalosporin-resistant (3GC-R) E. coli, which were recovered from 34.8% (cattle) and 47.8% (pigs) of samples from fecally contaminated sites. Phylogenetic analysis revealed substantial diversity suggestive of long-term horizontal and vertical transmission of 3GC-R mechanisms. CTX-M-15 and CTX-M-2 were more often produced by isolates from dairy farms, while CTX-M-8 and CMY-2 and co-carriage of amoxicillin/clavulanate resistance and florfenicol resistance were more common in isolates from pig farms. This suggests different selective pressures for antibiotic use in these two animal types. We identified the ß-lactamase gene blaROB, which has previously only been reported in the family Pasteurellaceae, in 3GC-R E. coli. blaROB was found alongside a novel florfenicol resistance gene, ydhC, also mobilized from a pig pathogen as part of a new composite transposon. As the first comprehensive genomic survey of 3GC-R E. coli in Argentina, these data set a baseline from which to measure the effects of interventions aimed at reducing on-farm ABR and provide an opportunity to investigate the zoonotic transmission of resistant bacteria in this region. IMPORTANCE: Little is known about the ecology of critically important antibiotic resistance among bacteria with the potential to be opportunistic human pathogens (e.g., Escherichia coli) on South American farms. By studying 70 pig and dairy cattle farms in central-eastern Argentina, we identified that third-generation cephalosporin resistance (3GC-R) in E. coli was mediated by mechanisms seen more often in certain species and that 3GC-R pig E. coli were more likely to be co-resistant to florfenicol and amoxicillin/clavulanate. This suggests that on-farm antibiotic usage is key to selecting the types of E. coli present on these farms. 3GC-R E. coli and 3GC-R plasmids were diverse, suggestive of long-term circulation in this region. We identified the de novo mobilization of the resistance gene blaROB from pig pathogens into E. coli on a novel mobile genetic element, which shows the importance of surveying poorly studied regions for antibiotic resistance that might impact human health.
Assuntos
Infecções por Escherichia coli , Escherichia coli , Tianfenicol/análogos & derivados , Animais , Humanos , Suínos , Bovinos , Escherichia coli/metabolismo , Fazendas , Cefalosporinas/farmacologia , Infecções por Escherichia coli/epidemiologia , Infecções por Escherichia coli/veterinária , Infecções por Escherichia coli/microbiologia , Filogenia , Antibacterianos/farmacologia , Antibacterianos/metabolismo , beta-Lactamases/genética , beta-Lactamases/metabolismo , Genômica , Amoxicilina , Ácido ClavulânicoRESUMO
BACKGROUND: Convenience stores in Guatemala provide essential consumer goods in communities, but many dispense antibiotics illegally. Federal legislation, passed in August of 2019, requires prescriptions for antibiotic purchase at pharmacies but it is unclear if this legislation is enforced or if it has any impact on unlawful sales of antibiotics. METHODS: To determine if antibiotic availability changed in convenience stores, we carried out a repeated measures study collecting antibiotic availability data before and after implementation of the dispensing regulation. RESULTS: There was no statistical difference in the proportion of convenience stores that sold antibiotics before and after antibiotic regulations [66.6% (295/443) and 66.7% (323/484), respectively, P>0.96], nor in the number of stores selling amoxicillin [55.5% (246/443) and 52.3% (253/484), respectively, P>0.96], but fewer stores (20%) sold tetracycline capsules after regulation was passed (P<0.05). For stores visited both before and after passage of legislation (n=157), 15% stopped selling antibiotics while 25% started selling antibiotics. Antibiotics from convenience stores were reportedly sold for use in people and animals. CONCLUSIONS: Antibiotics remain widely available in convenience stores consistent with no significant change in the informal sector after implementation of prescription requirements for pharmacies. Importantly, effects from regulatory change could have been masked by potential changes in antibiotic use during the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic.
Assuntos
Antibacterianos , Farmácias , Humanos , Antibacterianos/uso terapêutico , Comércio , Prescrições de Medicamentos , Amoxicilina , TetraciclinaRESUMO
The potentially toxic effects of emerging pollutant mixtures often deviate from the individual compound effects, presenting additive, synergistic, or agonistic interactions. This study delves into the complex world of emerging pollutants' mixtures, with a particular focus on their potential impact on unsaturated lipid DOPC (1,2-dioleoyl-sn-glycerol-3-phosphocholine) structured as both monolayers and bilayers, which are valuable tools for mimicking cell membranes. Specifically, we examine the effects of two common types of pollutants: antibiotics (amoxicillin) and dyes (methylene blue). Utilizing Langmuir monolayers, our research reveals a synergistic effect within the pollutant mixture, as evidenced by pressure-area isotherms and polarization-modulated infrared reflection absorption spectroscopy. We identify the specific chemical interactions contributing to this synergistic effect. Furthermore, through contrast phase microscopy experiments on giant unilamellar vesicles (bilayer system), we find that the individual pollutants and the mixture exhibit similar molecular effects on the bilayer, revealing that the molecular size is a key factor in the bilayer-mixture of pollutant interaction. This highlights the importance of considering molecular size in the interactions with bilayer systems. In summary, our research dissects the critical factors of chemical interactions and molecular size concerning the effects of pollutants on DOPC, serving as simplified models of cell membranes. This study underscores the significance of comprehending the molecular effects of emerging pollutants on human health and the development of models for exploring their intricate interactions with cell membranes.
Assuntos
Poluentes Ambientais , Lipossomas Unilamelares , Humanos , Lipossomas Unilamelares/química , Azul de Metileno , Fosfatidilcolinas/química , Amoxicilina , Bicamadas Lipídicas/químicaRESUMO
The use of antibiotics has increased considerably in the last decades in human medicine, as well as agriculture and animal production. Consequently, high loads of these emerging contaminants in the environment can increase antibiotic-resistant genes and the development of multi-resistant pathogenic microorganisms. This work aims to evaluate the removal of amoxicillin trihydrate in aqueous medium using mineral-activated carbon of bituminous origin as an adsorbent. The adsorbent was classified as microporous with associated mesopores, showing phenolic groups on its surface, which indicates the versatility of the adsorbent. The adsorption kinetics and isotherms were predominantly chemical. Pseudo-second-order model, as well as LDF model adjusted to the kinetic data. Sips and Langmuir isotherms adjusted to the adsorption equilibrium data. The maximum adsorptive capacity obtained experimentally was 313.30â mgâ g-1 at 50°C. The thermodynamic properties suggested spontaneous, monolayer, and endothermic adsorption. Overall, compared to previous works, the adsorbent proved to be a viable and promising alternative for the removal of antibiotics from water, with high adsorption capacity of amoxicillin, without being necessary to perform any prior changes to the material.
Assuntos
Amoxicilina , Carvão Vegetal , Animais , Humanos , Água , Adsorção , Antibacterianos , MineraisRESUMO
OBJECTIVES: This study evaluated antimicrobial activity of atorvastatin, pravastatin, rosuvastatin, and simvastatin against oral bacteria, and the interaction of simvastatin with standard antimicrobials (amoxicillin and metronidazole). METHODS: Minimal inhibitory concentration assays were performed with Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum, Actinomyces odontolyticus, Streptococcus oralis, Streptococcus mitis, Streptococcus salivarius, Streptococcus sanguinis, and Streptococcus gordonii; checkerboard microdilution assays between simvastatin and standard antimicrobials; monospecies and multispecies biofilms. RESULTS: Simvastatin showed the best antimicrobial activity against most species (MIC range from 3.12 to 25 µg/ml), highlighting the sensitivity of P. gingivalis. In the checkerboard assay, synergistic interaction was found between simvastatin and amoxicillin against S. oralis and S. sanguinis. P. gingivalis biofilm was inhibited by simvastatin at 10 and 50× Minimal inhibitory concentration, with similar effects to metronidazole. For multispecies biofilm, SMV reduced the biofilm metabolic activity (79%) and total counts (87%), comparable to amoxicillin. Simvastatin also reduced bacterial counts of Veilonnella parvula, P. gingivalis, Streptococcus mutans, Actinomyces naeslundii, P. intermedia, and Capnocytophaga ochracea in the multispecies biofilm. CONCLUSIONS: Simvastatin showed antimicrobial and antibiofilm activity against oral bacteria and may contribute to the control of dysbiosis, and may be considered in clinical studies as an adjuvant in the treatment of periodontitis.
Assuntos
Anti-Infecciosos , Inibidores de Hidroximetilglutaril-CoA Redutases , Humanos , Inibidores de Hidroximetilglutaril-CoA Redutases/farmacologia , Sinvastatina/farmacologia , Metronidazol/farmacologia , Disbiose , Biofilmes , Porphyromonas gingivalis , Amoxicilina , Fusobacterium nucleatumRESUMO
In this work, we are pleased to present for the first time a 3D-printed electrochemical device using a lab-made conductive filament based on graphite (Gr) and polylactic acid (PLA) polymer matrix for the simultaneous detection of amoxicillin (AMX) and paracetamol (PAR). The sensor was properly characterized by scanning electron microscopy (SEM), electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV). Compared to the commercial glassy carbon electrode (GCE), the superior performance of the 3D-Gr/PLA electrode was verified with a 3.8-fold more favored charge transfer. A differential pulse voltammetry (DPV) method was proposed providing a linear working range of 4 to 12 µmol L-1 for both analytes and a limit of detection (LOD) of 0.80 and 0.51 µmol L-1 for AMX and PAR, respectively. Additionally, repeatability studies (n = 5, RSD < 5.7%) indicated excellent precision, and recovery percentages ranging from 89 to 109% when applied to synthetic human urine, saliva, and plasma samples, attested to the accuracy of the method. The studies also indicate that the sensor does not suffer significant interference from common substances (antibiotics and biomarkers) present in the biological fluids, which makes it a promising analytical tool considering its low-cost, ease of manufacturing, robustness, and electrochemical performance.
Assuntos
Acetaminofen , Grafite , Humanos , Acetaminofen/química , Amoxicilina , Grafite/química , Eletrodos , Poliésteres , Impressão Tridimensional , Técnicas EletroquímicasRESUMO
Antibiotics and pesticides, as well as various emerging contaminants that are present in surface waters, raise significant environmental concerns. Advanced oxidation processes, which are employed to eliminate these substances, have demonstrated remarkable effectiveness. However, during the degradation process, by-products that are not completely mineralized are generated, posing a substantial risk to aquatic ecosystem organisms; therefore, it is crucial to assess effluent ecotoxicity following treatment. This study aimed to assess the toxicity of effluents produced during the removal of amoxicillin and glyphosate with a Fenton-type process using a laminar structure catalyzed with iron (Fe) and copper (Cu). The evaluation included the use of Daphnia magna, Selenastrum capricornutum, and Lactuca sativa, and mutagenicity testing was performed using strains TA98 and TA100 of Salmonella typhimurium. Both treated and untreated effluents exhibited inhibitory effects on root growth in L. sativa, even at low concentrations ranging from 1% to 10% v/v. Similarly, negative impacts on the growth of algal cells of S. capricornutum were observed at concentrations as low as 0.025% v/v, particularly in cases involving amoxicillin-copper (Cu) and glyphosate with copper (Cu) and iron (Fe). Notably, in the case of D. magna, mortality was noticeable even at concentrations of 10% v/v. Additionally, the treatment of amoxicillin with double-layer hydroxides of Fe and Cu resulted in mutagenicity (IM ≥ 2.0), highlighting the necessity to treat the effluent further from the advanced oxidation process to reduce ecological risks.
Assuntos
Amoxicilina , Cobre , Glifosato , Poluentes Químicos da Água , Amoxicilina/isolamento & purificação , Catálise , Cobre/química , Ecotoxicologia , Glifosato/isolamento & purificação , Ferro/química , Poluentes Químicos da Água/isolamento & purificaçãoRESUMO
Objetivo: Comparar el efecto de antibióticos pediátricos sobre la microdureza superficial del esmalte dental en dientes bovinos. Métodos: Se realizó un estudio in vitro en 60 dientes bovinos no cariados. Se sumergieron 15 dientes en cada grupo de cuatro soluciones (amoxicilina, amoxicilina + ácido clavulánico, eritromicina y saliva artificial) durante 1 minuto tres veces al día durante 7 y 14 días. Se midió la microdureza de la superficie del esmalte al inicio, a los7 y 14 días de exposición a los antibióticos. Resultados: La microdureza superficial del esmalte de los dientes de los grupos de antibióticos pediátricos se redujo después de 7 y 14 días de exposición con diferencia significativa (p < 0,001), respecto a la microdureza inicial. Además, en el grupo expuesto a saliva artificial no hubo diferencia significativa (p = 0,097) en los diferentes tiempos de evaluación. Conclusiones: Se concluye que los antibióticos pediátricos afectan la microdureza del esmalte, siendo la eritromicina la que mayor disminución generó a los 14 días de exposición(AU)
Objective: To compare the effect of pediatric antibiotics on the superficial microhardness of dental enamel in bovine teeth. Methods: An in vitro study was carried out on 60 non carious bovine teeth. Fifteen teeth were immersed in each group of four solutions (amoxicillin, amoxicillin + clavulanic acid, erythromycin and artificial saliva) for 1 minute three times a day for 7 and 14 days. Enamel surface microhardness was measured at baseline, 7 and 14 days of antibiotic exposure. Results: The enamel surface microhardness of the teeth of the pediatric antibiotic groups was reduced after seven and 14 days of exposure with significant difference (p < 0.001), with respect to the initial microhardness. In addition, in the group exposed to artificial saliva there was no significant difference (p = 0.097) at the different evaluation times. Conclusions: It is concluded that pediatric antibiotics affect enamel microhardness and erythromycin generated the greatest decrease at 14 days of exposure(AU)
Assuntos
Humanos , Criança , Amoxicilina/uso terapêutico , Antibacterianos/administração & dosagemRESUMO
Background: The most commonly reported antibiotic allergy is penicillin. The false label of "allergy" to penicillin negatively affects the patient's quality of life and medical care. Objective: To determine the frequency of allergy to penicillin and amoxicillin by in vivo exposure tests in patients with a history of immediate reaction to this class of medicinal products. Methods: Observational, cross-sectional, descriptive and prolective study in patients between 12 and 60 years of age with a history of immediate reaction to penicillin and/or amoxicillin. Prick and intradermal skin tests were performed with benzylpenicilloyl polylysine (Pre-Pen), penicillin G and oral challenge test with amoxicillin. The frequency of positivity and negativity in these tests was calculated with a 95% CI. Results were analyzed in Epi info 7.2.5.0. Results: In total 13 patients (10 women) were included, with a mean age of 39 years (SD 12.14). In 84.6% the last adverse drug reaction occurred 10 years ago and in all manifested with urticaria. The 38.4% confirmed penicillin allergy and the most frequent adverse reaction after in vivo tests was pruritus. Conclusions: The clinical history alone is not sufficient, all patients with suspected penicillin allergy should be evaluated by in vivo exposure tests with major and minor determinants to corroborate or rule out allergy to this pharmacological class.
Antecedentes: La alergia a antibióticos notificada con más frecuencia es la penicilina. La falsa etiqueta de "alergia" a la penicilina afecta negativamente la calidad de vida del paciente y la atención médica. Objetivo: Determinar la frecuencia de alergia a penicilina y amoxicilina mediante pruebas de exposición in vivo, en pacientes con antecedente de reacción inmediata a esta clase de medicamentos. Métodos: Estudio observacional, transversal, descriptivo y prolectivo en pacientes entre 12 y 60 años con antecedente de reacción inmediata a penicilina y/o amoxicilina. Se realizaron pruebas cutáneas por prick e intradérmicas con bencilpeniciloil polilisina y penicilina G, y prueba de reto oral con amoxicilina. La frecuencia de positividad y negatividad en estas pruebas fue calculado con un IC del 95%. Los resultados se analizaron en Epi info 7.2.5.0. Resultados: Se incluyeron 13 pacientes (10 mujeres), con una media de edad de 39 años (DE 12.14) y diagnóstico predominante de rinitis alérgica (61,5%). En 84,6% de casos la última reacción adversa a medicamentos ocurrió 10 años atrás y en todos se manifestó con urticaria. Sólo en cinco pacientes (38,4%) se corroboró alergia a penicilina y la reacción adversa más frecuente tras las pruebas in vivo fue prurito (23 %). Conclusiones: La historia clínica por sí sola no es suficiente, todos los pacientes con sospecha de alergia a penicilina deben ser evaluados mediante pruebas de exposición in vivo con los determinantes mayores y menores para corroborar o descartar alergia a esta clase farmacológica.